158 related articles for article (PubMed ID: 38191346)
1. Chronic restraint stress promotes oral squamous cell carcinoma development by inhibiting ALDH3A1 via stress response hormone.
Luo S; Long H; Lou F; Liu Y; Wang H; Pu J; Ji P; Jin X
BMC Oral Health; 2024 Jan; 24(1):43. PubMed ID: 38191346
[TBL] [Abstract][Full Text] [Related]
2. Chronic restraint stress promotes the tumorigenic potential of oral squamous cell carcinoma cells by reprogramming fatty acid metabolism via CXCL3 mediated Wnt/β-catenin pathway.
Lou F; Long H; Luo S; Liu Y; Pu J; Wang H; Ji P; Jin X
Exp Neurol; 2023 Jan; 359():114268. PubMed ID: 36343679
[TBL] [Abstract][Full Text] [Related]
3. ALDH3A1 overexpression in OSCC inhibits inflammation via phospho-Ser727 at STAT3 in tumor-associated macrophages.
Wang B; He Y; Wang B; Li J; Qin L
Oral Dis; 2023 May; 29(4):1513-1524. PubMed ID: 35188323
[TBL] [Abstract][Full Text] [Related]
4. ALDH3A1 acts as a prognostic biomarker and inhibits the epithelial mesenchymal transition of oral squamous cell carcinoma through IL-6/STAT3 signaling pathway.
Qu Y; He Y; Yang Y; Li S; An W; Li Z; Wang X; Han Z; Qin L
J Cancer; 2020; 11(9):2621-2631. PubMed ID: 32201532
[No Abstract] [Full Text] [Related]
5. The role and mechanism of circ-BNC2 on the malignant progression of oral squamous cell carcinoma.
Xia Y; Hei N; Peng S; Cui Z
Head Neck; 2023 Sep; 45(9):2424-2437. PubMed ID: 37377048
[TBL] [Abstract][Full Text] [Related]
6. Exosomal miR-146b-5p derived from cancer-associated fibroblasts promotes progression of oral squamous cell carcinoma by downregulating HIPK3.
He L; Guo J; Fan Z; Yang S; Zhang C; Cheng B; Xia J
Cell Signal; 2023 Jun; 106():110635. PubMed ID: 36813147
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial impairment and downregulation of Drp1 phosphorylation underlie the antiproliferative and proapoptotic effects of alantolactone on oral squamous cell carcinoma cells.
Zhang Y; Yang B; Tu C; Ping Y; Chen S; Wu T; Zhao Z; Mao Y; Yang Z; Cao Z; Li J; Huang K; Ding X; Wu G; Zou P; Deng Z; Sun X
J Transl Med; 2023 May; 21(1):328. PubMed ID: 37198593
[TBL] [Abstract][Full Text] [Related]
8. Inhibitor of Growth 4 (ING4) Plays a Tumor-repressing Role in Oral Squamous Cell Carcinoma via Nuclear Factor Kappa-B (NF-kB)/DNA Methyltransferase 1 (DNMT1) Axis-mediated Regulation of Aldehyde Dehydrogenase 1A2 (ALDH1A2).
Cui Z; Sun S; Li J; Li J; Sha T; He J; Zuo L
Curr Cancer Drug Targets; 2022; 22(9):771-783. PubMed ID: 35388759
[TBL] [Abstract][Full Text] [Related]
9. IL-1RA promotes oral squamous cell carcinoma malignancy through mitochondrial metabolism-mediated EGFR/JNK/SOX2 pathway.
Yuan SF; Wang YM; Chan LP; Hung AC; Nguyen HDH; Chen YK; Hu SC; Lo S; Wang YY
J Transl Med; 2023 Jul; 21(1):473. PubMed ID: 37461111
[TBL] [Abstract][Full Text] [Related]
10. ALDH3A1 upregulation inhibits neutrophils N2 polarization and halts oral cancer growth.
He Y; Qu Y; Jin S; Zhang Y; Qin L
Oral Dis; 2024 Jan; ():. PubMed ID: 38225738
[TBL] [Abstract][Full Text] [Related]
11. Carboxylesterase 2 induces mitochondrial dysfunction via disrupting lipid homeostasis in oral squamous cell carcinoma.
Chen X; Liu Q; Chen Y; Wang L; Yang R; Zhang W; Pan X; Zhang S; Chen C; Wu T; Xia J; Cheng B; Chen X; Ren X
Mol Metab; 2022 Nov; 65():101600. PubMed ID: 36113774
[TBL] [Abstract][Full Text] [Related]
12. Circ-KIAA0907 inhibits the progression of oral squamous cell carcinoma by regulating the miR-96-5p/UNC13C axis.
Dong W; Zhao L; Zhang S; Zhang S; Si H
World J Surg Oncol; 2021 Mar; 19(1):75. PubMed ID: 33715625
[TBL] [Abstract][Full Text] [Related]
13. miR-186-5p inhibits the progression of oral squamous cell carcinoma by targeting ITGA6 to impair the activity of the PI3K/AKT pathway.
Chen M; Zhang J
J Oral Pathol Med; 2022 Apr; 51(4):322-331. PubMed ID: 35201653
[TBL] [Abstract][Full Text] [Related]
14. CircZNF236 facilitates malignant progression in oral squamous cell carcinoma by sequestering miR-145-5p.
Lu Q; Che H; Che Y; Hu M
Clin Transl Oncol; 2023 Jun; 25(6):1690-1701. PubMed ID: 36635458
[TBL] [Abstract][Full Text] [Related]
15. Overproduced CPSF4 Promotes Cell Proliferation and Invasion via PI3K-AKT Signaling Pathway in Oral Squamous Cell Carcinoma.
Zhang M; Lin H; Ge X; Xu Y
J Oral Maxillofac Surg; 2021 May; 79(5):1177.e1-1177.e14. PubMed ID: 33535057
[TBL] [Abstract][Full Text] [Related]
16. Dihydroartemisinin represses oral squamous cell carcinoma progression through downregulating mitochondrial calcium uniporter.
Zheng S; Wu R; Deng Y; Zhang Q
Bioengineered; 2022 Jan; 13(1):227-241. PubMed ID: 34847839
[TBL] [Abstract][Full Text] [Related]
17. Assessment of multiple pathways involved in the inhibitory effect of HCG22 on oral squamous cell carcinoma progression.
Wang M; Feng Z; Li X; Sun S; Lu L
Mol Cell Biochem; 2021 Jun; 476(6):2561-2571. PubMed ID: 33649984
[TBL] [Abstract][Full Text] [Related]
18. ITGB2-mediated metabolic switch in CAFs promotes OSCC proliferation by oxidation of NADH in mitochondrial oxidative phosphorylation system.
Zhang X; Dong Y; Zhao M; Ding L; Yang X; Jing Y; Song Y; Chen S; Hu Q; Ni Y
Theranostics; 2020; 10(26):12044-12059. PubMed ID: 33204328
[No Abstract] [Full Text] [Related]
19. LncRNA HOXA11-AS promotes OSCC progression by sponging miR-98-5p to upregulate YBX2 expression.
Niu X; Yang B; Liu F; Fang Q
Biomed Pharmacother; 2020 Jan; 121():109623. PubMed ID: 31731187
[TBL] [Abstract][Full Text] [Related]
20. FOXN3 Expression Regulated by miR-299-5p Inhibiting the Proliferation, Migration and Invasion of Oral Squamous Cell Carcinoma Cells.
Maimaitiming K; Yilihamu A; Keyimu K; Keranmu R; Li J; Xu H; Wufuer D
Protein Pept Lett; 2022; 29(9):788-795. PubMed ID: 35975858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
